Comment on Johnson & Johnson: Stelara fares well in Crohn's disease

Johnson & Johnson: Stelara fares well in Crohn's disease

Johnson & Johnson's immune disorder drug Stelara significantly reduced symptoms of the inflammatory bowel condition Crohn's disease with just one infusion in about half the patients tested, according to the company.

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News